Differential Mechanisms of the Effect of Peroxisome Proliferator-Activated Receptor Gamma Agonists on Bleomycin-Induced Lung FibrosisReportar como inadecuado




Differential Mechanisms of the Effect of Peroxisome Proliferator-Activated Receptor Gamma Agonists on Bleomycin-Induced Lung Fibrosis - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Background and Objectives: Peroxisome proliferator-activated receptor-g PPAR-g is a nuclear receptor whose activation regulates inflammation and fibrosis in various organs. We aimed to investigate the effect of two PPAR-g ligands, telmisartan and rosiglitazone, on lung injury and fibrosis induced by intratracheal bleomycin BLM. Methods: Lung injury and fibrosis was induced in female C57Bl-6 mice by intratracheal instillation of 1.0 mg-kg of BLM. Some of the animals received rosiglitazone intraperitoneally or telmisartan in drinking water. Bronchoalveolar lavage BAL was performed 2, 7, 14 or 21 days after BLM instillation for cell counting and measurement of mediators in the lung. In a separate series, the lungs were sampled for collagen assay and histopathological evaluation. Results: Treatment with rosiglitazone or telmisartan significantly attenuated the BLM-induced increases in lung collagen content, pathological score, and inflammatory cells in BAL fluid. Rosiglitazone significantly suppressed BLM-induced elevation of TGF-b1, MCP-1, and IL-6 levels in the lung. In contrast, telmisartan made no changes in these cytokines, whereas it mitigated the BLM-induced increase in prostaglandin F2a in the lung. Higher concentrations of rosiglitazone and telmisartan attenuated proliferation of lung fibroblasts in vitro. Conclusions: Two PPAR-g ligands, rosiglitazone and telmisartan, exert protective effects on BLM-induced lung fibrosis through the suppression of different profibrotic mediators.

KEYWORDS

Peroxisome Proliferator-Activated Receptor-γ; Bleomycin; Pulmonary Fibrosis; Transforming Growth Factor-β1; Prostaglandin F2α

Cite this paper

K. Miyamoto, S. Tasaka, Y. Nakano, H. Shinoda, H. Kamata, W. Yamasawa, M. Ishii, N. Hasegawa and T. Betsuyaku -Differential Mechanisms of the Effect of Peroxisome Proliferator-Activated Receptor Gamma Agonists on Bleomycin-Induced Lung Fibrosis,- Open Journal of Respiratory Diseases, Vol. 3 No. 2, 2013, pp. 31-38. doi: 10.4236-ojrd.2013.32006.





Autor: Keisuke Miyamoto, Sadatomo Tasaka, Yasushi Nakano, Hiromi Shinoda, Hirofumi Kamata, Wakako Yamasawa, Makoto Ishii, Naoki Hasegawa

Fuente: http://www.scirp.org/



DESCARGAR PDF




Documentos relacionados